NCT02356107View on ClinicalTrials.gov

5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

5-hydroxytryptophan and Creatine monohydrate

Trial Locations (1)

84108

University of Utah/The Brain Institute, Salt Lake City

All Listed Sponsors
lead

Perry Renshaw

OTHER

NCT02356107 - 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females | Biotech Hunter | Biotech Hunter